| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-14022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-14021 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-15 |
| filingDate |
1992-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ceba127c1ea507d4471b7b56349fa52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21e918e7954023a7568ab802f6203f4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_472b8af2022b34355d349e53c4f85fce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43cce3ccc88bd03b633d9a64583fd8be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f31feadd8f86ac732943fb162cb5241d |
| publicationDate |
1993-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9303759-A1 |
| titleOfInvention |
Papua new guinea human t-lymphotropic virus |
| abstract |
The present invention relates to a human T-cell line (PNG-1) persistently infected with a Papua New Guinea (PNG) HTLV-I variant and to the infecting virus (PNG-1 variant). Cells of the present invention express viral antigens, type C particles and have a low level of reverse transcriptase activity. The establishment of this cell line, the first of its kind from an individual from Papua New Guinea, makes possible the screening of Melanesian populations using a local virus strain. The present invention also relates to vaccines for use in humans against infection with and diseases caused by HTLV-I and related viruses. The invention further relates to a variety of bioassays and kits for the detection and diagnosis of infection with and diseases caused by HTLV-I and related viruses. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9613608-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6221582-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9613608-A2 |
| priorityDate |
1991-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |